Humira, Rituxan top list of U.S. drugs with biggest price increases: report
AbbVie Inc's arthritis drug Humira and Roche Holding AG's cancer drug Rituxan topped a list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $5.1 billion increase in U.S. spending, a report released on Tuesday showed. [Source]
Publication Date:Origin: reuters.com
Category: healthNews
Topics: report, price, Rituxan, Humira, showed, released, spending, increase, billion, accounted, hikes, combined, whose, treatments, seven, topped, cancer, Holding, Roche, arthritis, Inc's, AbbVie, increases, biggest, drugs